PBBM Proud Of 3 Filipinos Who Visited All United Nations Member-States

Tatlong Pilipino ang kinilala ni PBBM sa kanilang pambihirang pagbisita sa lahat ng mga member-state ng United Nations. Isang tagumpay na dapat ipagmalaki.

New Law Giving Free Legal Aid To MUPs Signed

Ang bagong batas ay nagbibigay ng libreng legal na tulong para sa mga MUP. Ipinapakita ng administrasyon ang suporta sa mga tagapagtanggol ng bansa.

Tacloban Mangrove Park Eyed As Urban Green Space

Ang bagong urban green space sa Tacloban ay inaasahang makatutulong sa pagsugpo ng climate issues habang pinapangalagaan ang likas na yaman sa bayan ng Paraiso.

Aparri Marine Research Hub To Boost Blue Economy, Coastal Livelihood

Ang bagong marine research hub sa Aparri ay naglalayong palakasin ang likas-yaman ng dagat at tugunan ang kita ng mga komunidad sa baybayin.

Novel Vaccine For Triple-Negative Breast Cancer Enters Human Trials

Cleveland Clinic medical experts have officially started clinical testing of a novel vaccination that is intended to prevent triple-negative breast cancer.

Novel Vaccine For Triple-Negative Breast Cancer Enters Human Trials

0
0

How do you feel about this story?

Like
Love
Haha
Wow
Sad
Angry

Medical experts of Cleveland Clinic, a nonprofit multispecialty academic medical center, announced that they officially started clinical trials of the new vaccine that is designed to prevent triple-negative breast cancer (TNBC) last October 26.

After two decades of research and laboratory studies, the U.S. Food and Drug Administration (FDA) approved the investigational application for the vaccine which allows medical experts to move forward and conduct human trials.

“We are hopeful that this research will lead to more advanced trials to determine the effectiveness of the vaccine against this highly aggressive type of breast cancer,” said G. Thomas Budd, M.D., principal investigator of Cleveland Clinic Taussig Cancer Institute.

The phase-one of the human trials aims to determine the possible side effects and dosage of the vaccine to 18 – 24 patients, who have a history of Triple-Negative Breast Cancer (TNBC) and are currently tumor-free for three years.

Vincent Tuohy, Ph.D., the primary inventor of the vaccine and immunologist at Cleaveland Clinic stated that “our (Cleveland Clinic) research program focuses on developing vaccines that prevent diseases we confront with age, like breast, ovarian and endometrial cancers. If successful, these vaccines have the potential to transform the way we control adult-onset cancers and enhance life expectancy.”

Breast cancer is not a transmissible or infectious disease but according to World Health Organization, there were a total of 7.8 million women alive who were diagnosed with breast cancer in the past 5 years and 685,000 deaths globally.

This viable vaccine to prevent triple-negative breast cancer has the potential to represent a new way to prevent breast cancer and may also apply to other tumor types.

The study is estimated to be completed in September 2022.

Source: https://newsroom.clevelandclinic.org/2021/10/26/cleveland-clinic-launches-first-of-its-kind-preventive-breast-cancer-vaccine-study/, https://www.who.int/news-room/fact-sheets/detail/breast-cancer